References

Bernstein, D., and S. Lagakos. 1978. “Sample Size and Power Determination for Stratified Clinical Trials.” Journal of Statistical Computation and Simulation 8: 65–73.

Chan, Ivan S. F., and Norman R. Bohidar. 1998. “Exact Power and Sample Size for Vaccine Efficacy Studies.” Communications in Statistics - Theory and Methods 27 (6): 1305–22.

Freedman, L. S. 1982. “Tables of the Numbers of Patients Required in Clinical Trials Using the Log-Rank Test.” Statistics in Medicine 1: 121–29.

Jennison, Christopher, and Bruce W. Turnbull. 2000. Group Sequential Methods with Applications to Clinical Trials. Boca Raton, FL: Chapman; Hall/CRC.

Kim, Kyungmann, and Anastasios A. Tsiatis. 1990. “Study Duration for Clinical Trials with Survival Response and Early Stopping Rule.” Biometrics 46: 81–92.

Lachin, John M., and Mary A. Foulkes. 1986. “Evaluation of Sample Size and Power for Analyses of Survival with Allowance for Nonuniform Patient Entry, Losses to Follow-up, Noncompliance, and Stratification.” Biometrics 42: 507–19.

Schoenfeld, David. 1981. “The Asymptotic Properties of Nonparametric Tests for Comparing Survival Distributions.” Biometrika 68: 316–19.

Zhao, Yujie, Yilong Zhang, and Keaven M. Anderson. 2024. “Group Sequential Design Under Non-Proportional Hazards: Methodologies and Examples.” In Biostatistics in Biopharmaceutical Research and Development: Clinical Trial Design, Volume 1, 219–34. Springer.